1. Home
  2. NEPH vs BRNS Comparison

NEPH vs BRNS Comparison

Compare NEPH & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEPH
  • BRNS
  • Stock Information
  • Founded
  • NEPH 1997
  • BRNS 2016
  • Country
  • NEPH United States
  • BRNS United Kingdom
  • Employees
  • NEPH N/A
  • BRNS N/A
  • Industry
  • NEPH Medical/Dental Instruments
  • BRNS Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEPH Health Care
  • BRNS Health Care
  • Exchange
  • NEPH Nasdaq
  • BRNS Nasdaq
  • Market Cap
  • NEPH 36.1M
  • BRNS 40.0M
  • IPO Year
  • NEPH 2004
  • BRNS 2021
  • Fundamental
  • Price
  • NEPH $4.24
  • BRNS $0.92
  • Analyst Decision
  • NEPH Buy
  • BRNS Strong Buy
  • Analyst Count
  • NEPH 1
  • BRNS 1
  • Target Price
  • NEPH $5.00
  • BRNS $3.00
  • AVG Volume (30 Days)
  • NEPH 65.7K
  • BRNS 18.8K
  • Earning Date
  • NEPH 08-07-2025
  • BRNS 08-07-2025
  • Dividend Yield
  • NEPH N/A
  • BRNS N/A
  • EPS Growth
  • NEPH N/A
  • BRNS N/A
  • EPS
  • NEPH 0.08
  • BRNS N/A
  • Revenue
  • NEPH $15,517,000.00
  • BRNS $14,969,000.00
  • Revenue This Year
  • NEPH $17.06
  • BRNS N/A
  • Revenue Next Year
  • NEPH $12.20
  • BRNS N/A
  • P/E Ratio
  • NEPH $55.19
  • BRNS N/A
  • Revenue Growth
  • NEPH 10.34
  • BRNS 4381.74
  • 52 Week Low
  • NEPH $1.36
  • BRNS $0.64
  • 52 Week High
  • NEPH $5.00
  • BRNS $1.58
  • Technical
  • Relative Strength Index (RSI)
  • NEPH 61.33
  • BRNS 50.69
  • Support Level
  • NEPH $4.00
  • BRNS $0.83
  • Resistance Level
  • NEPH $5.00
  • BRNS $0.95
  • Average True Range (ATR)
  • NEPH 0.49
  • BRNS 0.05
  • MACD
  • NEPH 0.01
  • BRNS -0.01
  • Stochastic Oscillator
  • NEPH 55.56
  • BRNS 45.35

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.

Share on Social Networks: